<SEC-DOCUMENT>0001477932-21-003378.txt : 20210518
<SEC-HEADER>0001477932-21-003378.hdr.sgml : 20210518
<ACCEPTANCE-DATETIME>20210518090031
ACCESSION NUMBER:		0001477932-21-003378
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210518
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210518
DATE AS OF CHANGE:		20210518

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cosmos Holdings Inc.
		CENTRAL INDEX KEY:			0001474167
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				270611758
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54436
		FILM NUMBER:		21934045

	BUSINESS ADDRESS:	
		STREET 1:		141 W. JACKSON BLVD
		STREET 2:		SUITE 4236
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604
		BUSINESS PHONE:		312-536-3102

	MAIL ADDRESS:	
		STREET 1:		141 W. JACKSON BLVD
		STREET 2:		SUITE 4236
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIME ESTATES & DEVELOPMENTS INC
		DATE OF NAME CHANGE:	20091008
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cosm_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html><head><title>cosm_8k.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman; MARGIN: 0px 7%"><p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <table style="font-size:1px;width:100%"> <tr > <td style="BORDER-BOTTOM: 5px solid;"></td></tr> <tr > <td style="BORDER-BOTTOM: 2px solid;"></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:12pt">UNITED STATES</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:12pt">SECURITIES AND EXCHANGE COMMISSION</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:12pt">Washington, D.C. 20549</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>&nbsp;</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:18pt">FORM 8-K</font></strong> &nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>&nbsp;</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT</strong>&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Pursuant to Section 13 or 15(d) of the </strong><strong>Securities Exchange Act of 1934</strong> &nbsp; &nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Date of Report (Date of earliest event reported) <strong>May 18, 2021</strong>&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:100%;vertical-align:top;" colspan="4"> <p style="MARGIN: 0px; text-align:center;"><strong><font style="font-size:18pt">Cosmos Holdings Inc.</font></strong></p></td></tr> <tr style="height:15px"> <td colspan="4" style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:left;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: #000000 1px solid;width:30%;"> <p style="MARGIN: 0px; text-align:center;"><strong>Nevada</strong></p></td> <td style="width:5%;"> <p style="margin:0px"><strong>&nbsp;</strong></p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:30%;"> <p style="MARGIN: 0px; text-align:center;"><strong>000-54436</strong></p></td> <td style="width:5%;"> <p style="margin:0px"><strong>&nbsp;</strong></p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:30%;"> <p style="MARGIN: 0px; text-align:center;"><strong>27-0611758</strong></p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;">(State or other jurisdiction <br>of incorporation) </p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;">(Commission<br>File Number)&nbsp; </p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;">(I.R.S. Employer<br>Identification No.)</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:left;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: #000000 1px solid;width:45%;"> <p style="MARGIN: 0px; text-align:center;"><strong>141 West Jackson Blvd, Suite 4236, Chicago, Illinois </strong></p></td> <td style="width:10%;"> <p style="margin:0px"><strong>&nbsp;</strong></p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:45%;"> <p style="MARGIN: 0px; text-align:center;"><strong>60604</strong></p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:center;">(Address of principal executive offices)</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:center;">(Zip Code)</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Registrant&#8217;s telephone number, including area code&nbsp;<strong>(312) 865-0026</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>N/A</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Former name or former address, if changed since last report.)</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b of this chapter).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Emerging growth company &#9744;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp; &#9744;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td colspan="4" style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p></td></tr> <tr style="height:15px"> <td colspan="4"> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;">&#9744;</p></td> <td colspan="3" style="vertical-align:top;"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;">&#9744;</p></td> <td colspan="3" style="vertical-align:top;"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;">&#9744;</p></td> <td colspan="3" style="vertical-align:top;"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;">&#9744;</p></td> <td colspan="3" style="vertical-align:top;"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <table style="font-size:1px;width:100%"> <tr > <td style="BORDER-BOTTOM: 2px solid;"></td></tr> <tr > <td style="BORDER-BOTTOM: 5px solid;"></td></tr></table> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Item 2.02 &nbsp;Result of Operations and Financial Condition</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 18, 2021, Cosmos Holdings, Inc. (the &#8220;Company&#8221;) issued a press release announcing financial results for the first quarter of 2021. A copy of the press release titled &#8220;Cosmos Holdings Provides First Quarter 2021 Business Update; Reports 89% Year-Over-Year and 60% Sequential Increase in Nutraceutical Business&#8221; is attached hereto as 99.1 and is incorporated herein by reference. This information is intended to be furnished under this Item 2.02 of Form 8-K and shall not be deemed &#8220;Filed&#8221; for purposes of Section 18 of the Securities Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 9.01&nbsp; Financial Statements and Exhibits</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(d) Exhibits</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px;background-color:#cceeff"> <td style="width:8%;"> <p style="margin:0px"><a href="cosm_ex991.htm">Exhibit 99.1</a></p></td> <td style="width:2%;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px"><a href="cosm_ex991.htm">Press Release dated May 18, 2021</a></p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="MARGIN: 0px; text-align:center;">2</p></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td>&nbsp;</td> <td colspan="2"><strong>COSMOS HOLDINGS&nbsp;INC.</strong></td> <td></td></tr> <tr style="height:15px"> <td style="width:50%;">&nbsp;</td> <td style="width:3%;">&nbsp;</td> <td style="width:35%;">&nbsp;</td> <td style="width:12%;">&nbsp;</td></tr> <tr style="height:15px"> <td>Date:&nbsp;May 18, 2021&nbsp;</td> <td>By:</td> <td style="BORDER-BOTTOM: black 1px solid;"><em>/s/ Grigorios Siokas</em></td> <td></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">Grigorios Siokas</p></td> <td>&nbsp;</td></tr> <tr style="height:15px"> <td>&nbsp;</td> <td>&nbsp;</td> <td> <p style="margin:0px">Chief Executive Officer</p></td> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="MARGIN: 0px; text-align:center;">3</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cosm_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html><head><title>cosm_ex991.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 99.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><img src="cosm_ex991img1.jpg"> </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Cosmos Holdings Provides First Quarter 2021 Business Update; Reports 89%</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Year-Over-Year and </strong><strong>60% Sequential Increase in Nutraceutical Business</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>CHICAGO, May 18, 2021 (GLOBE NEWSWIRE) -- </strong><strong>Cosmos Holdings, Inc. </strong><strong>(&#8220;the Company") (OTCQX: </strong><strong>COSM</strong><strong>), </strong>a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European &nbsp;Union distribution network, today provided a business update and reported financial results for the first quarter ended March 31, 2021.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Greg Siokas, Chief Executive Officer of Cosmos Holdings, stated, "As anticipated, our revenue for the first quarter of 2021 decreased slightly due to the global pandemic and new Brexit rules that went into effect in January 2021, which had a temporary impact on our parallel trade business. Nevertheless, we continue to report the continued growth in our nutraceuticals business, which increased by 89% year over year and sequentially by 60% versus the fourth quarter of 2020.&nbsp; Looking ahead, we believe that in the coming quarters our full line wholesale revenue will outpace the temporary decrease in our parallel trade revenue, which in turn, should also improve as the market adapts to the new Brexit rules.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#8220;We launched four new Sky Premium Life products: Bodyguard, Osteodome, King Eros and Queen Venus. We also launched Mosept-Oral, a new, proprietary oral antiseptic spray designed to be effective against bacteria, certain viruses and fungi, as well as for the symptomatic relief of painful, irritated sore throats. We believe that the introduction of new branded pharmaceuticals and new nutraceuticals into international markets will become major drivers of our revenue growth and profitability in coming quarters, as we have built a robust distribution network, which now includes relationships with over 160 wholesale pharmaceutical distributors across Europe&#8217;s largest markets, with access to over 50,000 pharmacies.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#8220;Most recently, our subsidiary, Decahedron Ltd, a UK-based pharmaceutical wholesaler, distributor and fulfillment center, initiated the launch of Sky Premium Life products on Amazon United Kingdom (UK) and we expect to have all 65 Sky Premium Life SKUs listed on Amazon UK by the end of this year. The Amazon UK initiative is major step forward in the roll-out of our e-commerce and online global distribution strategy. Launching our Sky Premium Life products on Amazon UK is expected to provide us the opportunity for exponential growth, driven by the increasing global demand for vitamins, minerals and dietary supplements, as well as the shift towards e-commerce shopping. In addition, we continue to add distributors worldwide and expect to enter a number of new European and global markets later this year.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#8220;It&#8217;s important to note that we are investing heavily in R&amp;D and marketing of our proprietary line of branded pharmaceuticals, nutraceuticals and food supplements. Also in our results of operations are included $1.2 million of non-cash, stock-based compensation expenses related to international consulting activities, all of which we believe will help drive our future success. Finally, we are working towards our goal of uplisting to a national securities exchange, which we believe will enhance Cosmos&#8217; visibility in the investment community and help increase the liquidity of the stock, supporting our goal of building long-term shareholder value as we execute on a number of key initiatives this year.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp;</p> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td colspan="9"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td colspan="9" style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in"><strong>Consolidated Statements of Operations and Comprehensive Income (Loss)</strong></p></td></tr> <tr style="height:15px"> <td colspan="9"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Three Months Ended March 31,</strong></p></td> <td style="white-space: nowrap;"> <p style="margin:0px"><strong>&nbsp;</strong></p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px"><strong>&nbsp;</strong></p></td> <td style="white-space: nowrap;"> <p style="margin:0px"><strong>&nbsp;</strong></p></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> <p style="margin:0px"><strong>&nbsp;</strong></p></td> <td style="white-space: nowrap;"> <p style="margin:0px"><strong>&nbsp;</strong></p></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2020</strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in">REVENUE</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,619,076</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,933,248</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in">COST OF GOODS SOLD</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">10,617,741</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">10,740,077</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in">GROSS PROFIT</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,001,335</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,193,171</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in">INCOME (LOSS) FROM OPERATIONS</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,731,098</td> <td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">225,564</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in">NET LOSS</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,173,903</td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(483,310 </td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in">BASIC NET LOSS PER SHARE</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(0.14</td> <td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(0.04 </td> <td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in">DILUTED NET LOSS PER SHARE</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(0.14</td> <td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(0.04 </td> <td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in">Basic</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">15,034,219</td> <td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">13,225,387</td> <td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="margin:0px 0px 0px 0in">Diluted</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">15,034,219</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">13,228,387</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>About Cosmos Holdings, Inc.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cosmos Holdings Inc., is an international pharmaceutical company, with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices and an extensive, established EU distribution network. The Company identifies, acquires, develops and commercializes products that improve patients' lives and outcomes and has an extensive network of clients in Germany, United Kingdom, United Arab Emirates, Denmark, Italy, France, Singapore, Ireland, Sweden, Poland, Netherlands, and Greece. Cosmos Holdings has offices and distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, UK. More information is available at www.cosmosholdingsinc.com and www.skypremiumlife.com. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Forward-Looking Statements</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;estimates,&#8221; &#8220;plans&#8221; and similar expressions or future or conditional verbs such as &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;may&#8221; and &#8220;could&#8221;, are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company&#8217;s ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic on the Company&#8217;s business, operations and the economy in general, and the Company&#8217;s ability to successfully develop and commercialize its proprietary products and technologies. Readers, are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company&#8217;s filings with the SEC, which are available at the SEC&#8217;s website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Investor Relations Contact:</strong><br>Crescendo Communications, LLC<br>Tel: 212-671-1020<br>Email:&nbsp;COSM@crescendo-ir.com </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>cosm_ex991img1.jpg
<TEXT>
begin 644 cosm_ex991img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  S )P# 2(  A$! Q$!_\0
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MJ!BI/*CX'EK@'<..A]:** (TM;:%"(;>.,%MV%4#GUI$L[2$;(K:)%)R0J
MFBB@#FO&$K0:1B-4 D8!@44Y&WW%=$MG:S6,5O-;I+$JC".NX#CWHHH ?]DM
M?-,WV>/S"NPMM&2OI]*AOX8O[,NF\M<^4S9QWVD?RHHH +:PLOL$4/V2+R\*
L^W8,;L=?K4LD<<<#ND:JR@L"%'!V]:** (M)18]&LU1<+Y2\?A5ZBB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
